These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8835302)

  • 1. Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats.
    Ejersted C; Andreassen TT; Hauge EM; Melsen F; Oxlund H
    Bone; 1995 Dec; 17(6):507-11. PubMed ID: 8835302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats.
    Ejersted C; Oxlund H; Eriksen EF; Andreassen TT
    Bone; 1998 Jul; 23(1):43-52. PubMed ID: 9662129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate maintains parathyroid hormone (1-34)-induced cortical bone mass and mechanical strength in old rats.
    Ejersted C; Oxlund H; Andreassen TT
    Calcif Tissue Int; 1998 Apr; 62(4):316-22. PubMed ID: 9504956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats.
    Ejersted C; Andreassen TT; Nilsson MH; Oxlund H
    Eur J Endocrinol; 1994 Feb; 130(2):201-7. PubMed ID: 8130897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model.
    Søgaard CH; Mosekilde L; Thomsen JS; Richards A; McOsker JE
    Bone; 1997 May; 20(5):439-49. PubMed ID: 9145241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of parathyroid hormone on rat lumbar vertebrae.
    Sehmisch S; Erren M; Rack T; Tezval M; Seidlova-Wuttke D; Richter J; Wuttke W; Stuermer KM; Stuermer EK
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2014-21. PubMed ID: 19730209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles.
    Zhang L; Takahashi HE; Inoue J; Tanizawa T; Endo N; Yamamoto N; Hori M
    Bone; 1997 Dec; 21(6):501-6. PubMed ID: 9430239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment.
    Sato M; Ma YL; Hock JM; Westmore MS; Vahle J; Villanueva A; Turner CH
    J Pharmacol Exp Ther; 2002 Jul; 302(1):304-13. PubMed ID: 12065731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).
    Mosekilde L; Søgaard CH; Danielsen CC; Tørring O
    Endocrinology; 1991 Jul; 129(1):421-8. PubMed ID: 2055197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic effect of parathyroid hormone is not modified by supplementation with insulinlike growth factor I (IGF-I) or growth hormone in aged female rats fed an energy-restricted or ad libitum diet.
    Gunness M; Hock JM
    Bone; 1995 Feb; 16(2):199-207. PubMed ID: 7756048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration.
    Kishi T; Hagino H; Kishimoto H; Nagashima H
    Bone; 1998 May; 22(5):515-22. PubMed ID: 9600786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats.
    Toromanoff A; Ammann P; Riond JL
    Bone; 1998 Mar; 22(3):217-23. PubMed ID: 9514214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of human parathyroid hormone 1-34 on bone loss and lumbar intervertebral disc degeneration in ovariectomized rats.
    Luo Y; Li SY; Tian FM; Song HP; Zhang YZ; Zhang L
    Int Orthop; 2018 May; 42(5):1183-1190. PubMed ID: 29442158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.